Africa on the Brink of MPox Vaccination: A Collaborative Effort to Combat the Virus

At a recent press briefing, Dr. Jean Kaseya, the Director-General of Africa's CDC, announced promising news regarding the MPox vaccination efforts in the Democratic Republic of the Congo (DRC) and other African nations. He confirmed that with doses donated from various countries, vaccination campaigns are set to commence within days. "We have not started vaccinating yet but we will start soon if we are sure that everything is in place. By the end of next week, vaccines will begin to arrive in the DRC and other countries," Kaseya stated.

This proactive approach comes at a crucial time as Africa's CDC engages in discussions with Danish vaccine manufacturer Bavarian Nordic. The focus is on facilitating technology transfer, which would enable local manufacturers in Africa to produce the MPox vaccine independently. If an agreement is reached, this initiative could significantly enhance the continent's capacity to combat outbreaks locally.

In a broader context, the ongoing conversations about MPox were underscored by remarks from the WHO's European chief, Hans Kluge. He urged the public to remain calm, stating, "We know how to handle MPox and what is required to completely stop the spread in Europe." Despite the World Health Organization classifying the outbreak as an international health emergency last week, Kluge emphasized that it should not be seen in the same light as COVID-19.

The urgency of vaccination comes on the heels of concerning trends. Between August 13 and August 20, Africa reported nearly 1,400 new MPox cases. To date, there have been close to 19,000 cases and 541 deaths confirmed this year. While concerns grow, the risk of transmission in Europe remains relatively low, despite a confirmed case of the more dangerous variant, clade 1b, in Stockholm, marking the strain's first appearance outside Africa.

The situation in Africa highlights the importance of international cooperation and readiness in public health responses. With the African CDC's efforts and potential local production of vaccines, there is hope that countries on the continent will soon be equipped to tackle MPox more effectively. The coming days will be critical as nations prepare for the arrival of vaccines and mobilize their public health infrastructure to ensure a swift response to this outbreak.

Related Sources:

• Source 1 • Source 2